Yahoo
NasdaqGM - Delayed Quote USD

NeuroPace, Inc. (NPCE)

14.90 +0.15 (+1.02%)
At close: 4:00:00 PM EDT
14.90 0.00 (0.00%)
After hours: 4:10:04 PM EDT
Trade NPCE on Coinbase
Chart Range Bar
Loading chart for NPCE
  • Previous Close 14.75
  • Open 14.62
  • Bid 10.16 x 200
  • Ask 17.12 x 200
  • Day's Range 14.47 - 14.90
  • 52 Week Range 9.22 - 19.60
  • Volume 92,319
  • Avg. Volume 187,449
  • Market Cap (intraday) 511.432M
  • Beta (5Y Monthly) 1.95
  • PE Ratio (TTM) --
  • EPS (TTM) -0.47
  • Earnings Date Nov 3, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 20.22

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

www.neuropace.com

220

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NPCE
3.50%
S&P 500 (^GSPC)
12.75%

1-Year Return

NPCE
55.05%
S&P 500 (^GSPC)
18.71%

3-Year Return

NPCE
66.85%
S&P 500 (^GSPC)
70.93%

5-Year Return

NPCE
37.34%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 26.59M
Earnings -2.73M
Profit Margin -10.26%

Q2

FY25

Q3

FY25

Q4

FY25

0
10M
20M
-35.0%
-30.0%
-25.0%
-20.0%
-15.0%

Analyst Insights

View More

Analyst Price Targets

18.00
20.22 Average
14.90 Current
22.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 7/29/2026
Analyst HC Wainwright & Co.
Rating Action Reiterates
Rating Buy
Price Action Maintains
Price Target 20 -> 20

Statistics

View More

Valuation Measures

Annual
As of 9/1/2026
  • Market Cap

    505.25M

  • Enterprise Value

    523.49M

  • Trailing P/E

    --

  • Forward P/E

    163.93

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.62

  • Price/Book (mrq)

    42.52

  • Enterprise Value/Revenue

    4.89

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -17.86%

  • Return on Assets (ttm)

    -7.47%

  • Return on Equity (ttm)

    -103.27%

  • Revenue (ttm)

    106.99M

  • Net Income Avi to Common (ttm)

    -16.17M

  • Diluted EPS (ttm)

    -0.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    51.7M

  • Total Debt/Equity (mrq)

    588.50%

  • Levered Free Cash Flow (ttm)

    -2.63M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

14.90 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: